These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 34259140)
1. Six CT83-related Genes-based Prognostic Signature for Lung Adenocarcinoma. Wang Y; Zhang G; Wang R Comb Chem High Throughput Screen; 2022; 25(9):1565-1575. PubMed ID: 34259140 [TBL] [Abstract][Full Text] [Related]
2. A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining. Liu J; Hou S; Wang J; Chai Z; Hong X; Zhao T; Sun Z; Bai L; Gao H; Gao J; Chen G Oxid Med Cell Longev; 2020; 2020():8847226. PubMed ID: 33414898 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma. Ren J; Wang A; Liu J; Yuan Q Bioengineered; 2021 Dec; 12(1):4331-4348. PubMed ID: 34338158 [TBL] [Abstract][Full Text] [Related]
4. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma. Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465 [TBL] [Abstract][Full Text] [Related]
5. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns. Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675 [TBL] [Abstract][Full Text] [Related]
6. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma. Jiang H; Xu S; Chen C BMC Cancer; 2020 Aug; 20(1):782. PubMed ID: 32819300 [TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes. Li F; Niu Y; Zhao W; Yan C; Qi Y Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857 [TBL] [Abstract][Full Text] [Related]
8. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
9. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma. Wu C; Rao X; Lin W Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730 [TBL] [Abstract][Full Text] [Related]
10. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325 [TBL] [Abstract][Full Text] [Related]
11. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma. Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W Front Immunol; 2022; 13():992626. PubMed ID: 36311724 [TBL] [Abstract][Full Text] [Related]
12. A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma. Wang X; Zhao C; Huang D; Liu Z; Liu M; Lin F; Lu Y; Jia J; Lin L; Lin X; Li H; Chen Z Front Immunol; 2022; 13():923533. PubMed ID: 35860262 [TBL] [Abstract][Full Text] [Related]
13. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data. He J; Zhang W; Li F; Yu Y Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518 [TBL] [Abstract][Full Text] [Related]
14. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
15. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma. Li F; Ge D; Sun SL BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754 [TBL] [Abstract][Full Text] [Related]
16. Establishment and Evaluation of a 6-Gene Survival Risk Assessment Model Related to Lung Adenocarcinoma Microenvironment. Wang Z; Xu H; Zhu L; He T; Lv W; Wu Z Biomed Res Int; 2020; 2020():6472153. PubMed ID: 32337264 [TBL] [Abstract][Full Text] [Related]
17. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma. Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739 [TBL] [Abstract][Full Text] [Related]
18. Identification Six Metabolic Genes as Potential Biomarkers for Lung Adenocarcinoma. Zhang S; Lu Y; Liu Z; Li X; Wang Z; Cai Z J Comput Biol; 2020 Oct; 27(10):1532-1543. PubMed ID: 32298601 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
20. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches. Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S PeerJ; 2023; 11():e16166. PubMed ID: 37790630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]